APO Research
Talk to an analyst

APO RESEARCH · REPORT

Roxithromycin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Roxithromycin Industry Growth and Trends Forecast to 2032

31 December 2025102 pages

Choose your research edition.

Industry ResearchRoxithromycin Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Roxithromycin Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Roxithromycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Roxithromycin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Roxithromycin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Roxithromycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Roxithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Roxithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Roxithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Roxithromycin include Zhejiang Zhenyuan Pharmaceutical, Johnson & Johnson, Bayer AG, Valeant Pharmaceutical International, Stiefel Laboratories, Sigma-Aldrich, Hygeia Laboratories, Hovione and Hetero Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Roxithromycin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Roxithromycin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Roxithromycin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Roxithromycin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Roxithromycin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Roxithromycin Market by Company

Zhejiang Zhenyuan Pharmaceutical

Johnson & Johnson

Bayer AG

Valeant Pharmaceutical International

Stiefel Laboratories

Sigma-Aldrich

Hygeia Laboratories

Hovione

Hetero Healthcare

Galderma SA

Finecure Pharmaceuticals

Cipher

Allergan

Roxithromycin Segment by Type

Roxithromycin Tablets

Roxithromycin Granules

Roxithromycin Capsules

Roxithromycin Segment by Application

Respiratory Tract Infections

Urinary Infections

Soft Tissue Infections

Roxithromycin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Roxithromycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Roxithromycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Roxithromycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Roxithromycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Roxithromycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Roxithromycin Tablets Table 2. Major Company of Roxithromycin Granules Table 3. Major Company of Roxithromycin Capsules Table 4. Global Roxithromycin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Roxithromycin Sales by Type (2021-2026) & (K Units) Table 6. Global Roxithromycin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Roxithromycin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Roxithromycin Sales Market Share in Value by Type (2021-2026) Table 9. Global Roxithromycin Price by Type (2021-2026) & (US$/Unit) Table 10. Global Roxithromycin Sales by Type (2027-2032) & (K Units) Table 11. Global Roxithromycin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Roxithromycin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Roxithromycin Sales Market Share in Value by Type (2027-2032) Table 14. Global Roxithromycin Price by Type (2027-2032) & (US$/Unit) Table 15. North America Roxithromycin Sales by Type (2021-2026) & (K Units) Table 16. North America Roxithromycin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Roxithromycin Sales by Type (2021-2026) & (K Units) Table 18. Europe Roxithromycin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Roxithromycin Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Roxithromycin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Roxithromycin Sales by Type (2021-2026) & (K Units) Table 22. Latin America Roxithromycin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Roxithromycin Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Roxithromycin Sales by Type (2021-2026) & (US$ Million) Table 25. Roxithromycin Industry Trends Table 26. Roxithromycin Industry Drivers Table 27. Roxithromycin Industry Opportunities and Challenges Table 28. Roxithromycin Industry Restraints Table 29. Global Roxithromycin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Roxithromycin Revenue Market Share by Company (2021-2026) Table 31. Global Roxithromycin Sales by Company (2021-2026) & (K Units) Table 32. Global Roxithromycin Sales Share by Company (2021-2026) Table 33. Global Roxithromycin Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Roxithromycin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Roxithromycin Major Company Production Sites and Headquarters Table 36. Global Roxithromycin Company, Product Type & Application Table 37. Global Roxithromycin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Roxithromycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Roxithromycin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Roxithromycin Sales by Region (2021-2026) & (K Units) Table 42. Global Roxithromycin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Roxithromycin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Roxithromycin Sales Market Share in Value by Region (2021-2026) Table 45. Global Roxithromycin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Roxithromycin Sales by Region (2027-2032) & (K Units) Table 47. Global Roxithromycin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Roxithromycin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Roxithromycin Sales Market Share in Value by Region (2027-2032) Table 50. Global Roxithromycin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Roxithromycin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Roxithromycin Sales by Application (2021-2026) & (K Units) Table 53. Global Roxithromycin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Roxithromycin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Roxithromycin Sales Market Share in Value by Application (2021-2026) Table 56. Global Roxithromycin Price by Application (2021-2026) & (US$/Unit) Table 57. Global Roxithromycin Sales by Application (2027-2032) & (K Units) Table 58. Global Roxithromycin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Roxithromycin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Roxithromycin Sales Market Share in Value by Application (2027-2032) Table 61. Global Roxithromycin Price by Application (2027-2032) & (US$/Unit) Table 62. North America Roxithromycin Sales by Application (2021-2026) & (K Units) Table 63. North America Roxithromycin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Roxithromycin Sales by Application (2021-2026) & (K Units) Table 65. Europe Roxithromycin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Roxithromycin Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Roxithromycin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Roxithromycin Sales by Application (2021-2026) & (K Units) Table 69. Latin America Roxithromycin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Roxithromycin Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Roxithromycin Sales by Application (2021-2026) & (US$ Million) Table 72. Zhejiang Zhenyuan Pharmaceutical Company Information Table 73. Zhejiang Zhenyuan Pharmaceutical Business Overview Table 74. Zhejiang Zhenyuan Pharmaceutical Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Zhejiang Zhenyuan Pharmaceutical Roxithromycin Product Portfolio Table 76. Zhejiang Zhenyuan Pharmaceutical Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Roxithromycin Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Bayer AG Company Information Table 83. Bayer AG Business Overview Table 84. Bayer AG Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Bayer AG Roxithromycin Product Portfolio Table 86. Bayer AG Recent Development Table 87. Valeant Pharmaceutical International Company Information Table 88. Valeant Pharmaceutical International Business Overview Table 89. Valeant Pharmaceutical International Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Valeant Pharmaceutical International Roxithromycin Product Portfolio Table 91. Valeant Pharmaceutical International Recent Development Table 92. Stiefel Laboratories Company Information Table 93. Stiefel Laboratories Business Overview Table 94. Stiefel Laboratories Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Stiefel Laboratories Roxithromycin Product Portfolio Table 96. Stiefel Laboratories Recent Development Table 97. Sigma-Aldrich Company Information Table 98. Sigma-Aldrich Business Overview Table 99. Sigma-Aldrich Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sigma-Aldrich Roxithromycin Product Portfolio Table 101. Sigma-Aldrich Recent Development Table 102. Hygeia Laboratories Company Information Table 103. Hygeia Laboratories Business Overview Table 104. Hygeia Laboratories Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hygeia Laboratories Roxithromycin Product Portfolio Table 106. Hygeia Laboratories Recent Development Table 107. Hovione Company Information Table 108. Hovione Business Overview Table 109. Hovione Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hovione Roxithromycin Product Portfolio Table 111. Hovione Recent Development Table 112. Hetero Healthcare Company Information Table 113. Hetero Healthcare Business Overview Table 114. Hetero Healthcare Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hetero Healthcare Roxithromycin Product Portfolio Table 116. Hetero Healthcare Recent Development Table 117. Galderma SA Company Information Table 118. Galderma SA Business Overview Table 119. Galderma SA Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Galderma SA Roxithromycin Product Portfolio Table 121. Galderma SA Recent Development Table 122. Finecure Pharmaceuticals Company Information Table 123. Finecure Pharmaceuticals Business Overview Table 124. Finecure Pharmaceuticals Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Finecure Pharmaceuticals Roxithromycin Product Portfolio Table 126. Finecure Pharmaceuticals Recent Development Table 127. Cipher Company Information Table 128. Cipher Business Overview Table 129. Cipher Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Cipher Roxithromycin Product Portfolio Table 131. Cipher Recent Development Table 132. Allergan Company Information Table 133. Allergan Business Overview Table 134. Allergan Roxithromycin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Allergan Roxithromycin Product Portfolio Table 136. Allergan Recent Development Table 137. North America Roxithromycin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Roxithromycin Sales by Country (2021-2026) & (K Units) Table 139. North America Roxithromycin Sales Market Share by Country (2021-2026) Table 140. North America Roxithromycin Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Roxithromycin Sales Market Share Forecast by Country (2027-2032) Table 142. North America Roxithromycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Roxithromycin Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Roxithromycin Market Share by Country (2021-2026) Table 145. North America Roxithromycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Roxithromycin Market Share Forecast by Country (2027-2032) Table 147. Europe Roxithromycin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Roxithromycin Sales by Country (2021-2026) & (K Units) Table 149. Europe Roxithromycin Sales Market Share by Country (2021-2026) Table 150. Europe Roxithromycin Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Roxithromycin Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Roxithromycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Roxithromycin Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Roxithromycin Market Share by Country (2021-2026) Table 155. Europe Roxithromycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Roxithromycin Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Roxithromycin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Roxithromycin Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Roxithromycin Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Roxithromycin Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Roxithromycin Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Roxithromycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Roxithromycin Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Roxithromycin Market Share by Country (2021-2026) Table 165. Asia-Pacific Roxithromycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Roxithromycin Market Share Forecast by Country (2027-2032) Table 167. Latin America Roxithromycin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Roxithromycin Sales by Country (2021-2026) & (K Units) Table 169. Latin America Roxithromycin Sales Market Share by Country (2021-2026) Table 170. Latin America Roxithromycin Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Roxithromycin Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Roxithromycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Roxithromycin Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Roxithromycin Market Share by Country (2021-2026) Table 175. Latin America Roxithromycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Roxithromycin Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Roxithromycin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Roxithromycin Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Roxithromycin Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Roxithromycin Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Roxithromycin Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Roxithromycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Roxithromycin Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Roxithromycin Market Share by Country (2021-2026) Table 185. Middle East and Africa Roxithromycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Roxithromycin Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Roxithromycin Distributors List Table 190. Roxithromycin Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Roxithromycin Image Figure 2. Global Roxithromycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Roxithromycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Roxithromycin Sales (2021-2032) & (K Units) Figure 5. Roxithromycin Tablets Image Figure 6. Global Roxithromycin Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Roxithromycin Granules Image Figure 8. Global Roxithromycin Granules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Roxithromycin Capsules Image Figure 10. Global Roxithromycin Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Roxithromycin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Roxithromycin Market Share by Type 2025 VS 2032 Figure 13. North America Roxithromycin Sales Market Share in Volume by Type in 2025 Figure 14. North America Roxithromycin Sales Market Share in Value by Type in 2025 Figure 15. Europe Roxithromycin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Roxithromycin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Roxithromycin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Roxithromycin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Roxithromycin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Roxithromycin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Roxithromycin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Roxithromycin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Roxithromycin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Respiratory Tract Infections Image Figure 26. Global Respiratory Tract Infections Sales YoY Growth (2021-2032) & (K Units) Figure 27. Urinary Infections Image Figure 28. Global Urinary Infections Sales YoY Growth (2021-2032) & (K Units) Figure 29. Soft Tissue Infections Image Figure 30. Global Soft Tissue Infections Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Roxithromycin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Roxithromycin Market Share by Application 2025 VS 2032 Figure 33. North America Roxithromycin Sales Market Share in Volume by Application in 2025 Figure 34. North America Roxithromycin Sales Market Share in Value by Application in 2025 Figure 35. Europe Roxithromycin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Roxithromycin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Roxithromycin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Roxithromycin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Roxithromycin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Roxithromycin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Roxithromycin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Roxithromycin Sales Market Share in Value by Application in 2025 Figure 43. North America Roxithromycin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Roxithromycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Roxithromycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Roxithromycin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Roxithromycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Roxithromycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Roxithromycin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Roxithromycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Roxithromycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Roxithromycin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Roxithromycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Roxithromycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Roxithromycin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Roxithromycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Roxithromycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Roxithromycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Roxithromycin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Roxithromycin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Roxithromycin Tablets
  • Roxithromycin Granules
  • Roxithromycin Capsules
Applications
  • Respiratory Tract Infections
  • Urinary Infections
  • Soft Tissue Infections
Companies covered
  • Zhejiang Zhenyuan Pharmaceutical
  • Johnson & Johnson
  • Bayer AG
  • Valeant Pharmaceutical International
  • Stiefel Laboratories
  • Sigma-Aldrich
  • Hygeia Laboratories
  • Hovione
  • Hetero Healthcare
  • Galderma SA
  • Finecure Pharmaceuticals
  • Cipher
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Roxithromycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Roxithromycin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Roxithromycin Market by Type
  6. 1.3.1 Roxithromycin Tablets
  7. 1.3.2 Roxithromycin Granules
  8. 1.3.3 Roxithromycin Capsules
  9. 1.4 Global Roxithromycin Market Size by Type
  10. 1.4.1 Global Roxithromycin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Roxithromycin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Roxithromycin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Roxithromycin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Roxithromycin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Roxithromycin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Roxithromycin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Roxithromycin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Roxithromycin Industry Trends
  2. 2.2 Roxithromycin Industry Drivers
  3. 2.3 Roxithromycin Industry Opportunities and Challenges
  4. 2.4 Roxithromycin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Roxithromycin Revenue (2021-2026)
  2. 3.2 Global Top Players by Roxithromycin Sales (2021-2026)
  3. 3.3 Global Top Players by Roxithromycin Price (2021-2026)
  4. 3.4 Global Roxithromycin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Roxithromycin Major Company Production Sites & Headquarters
  6. 3.6 Global Roxithromycin Company, Product Type & Application
  7. 3.7 Global Roxithromycin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Roxithromycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Roxithromycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Roxithromycin Tier 1, Tier 2, and Tier 3
4 Roxithromycin Regional Status and Outlook
  1. 4.1 Global Roxithromycin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Roxithromycin Historic Market Size by Region
  3. 4.2.1 Global Roxithromycin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Roxithromycin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Roxithromycin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Roxithromycin Forecasted Market Size by Region
  7. 4.3.1 Global Roxithromycin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Roxithromycin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Roxithromycin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Roxithromycin by Application
  1. 5.1 Roxithromycin Market by Application
  2. 5.1.1 Respiratory Tract Infections
  3. 5.1.2 Urinary Infections
  4. 5.1.3 Soft Tissue Infections
  5. 5.2 Global Roxithromycin Market Size by Application
  6. 5.2.1 Global Roxithromycin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Roxithromycin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Roxithromycin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Roxithromycin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Roxithromycin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Roxithromycin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Roxithromycin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Roxithromycin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Zhenyuan Pharmaceutical
  2. 6.1.1 Zhejiang Zhenyuan Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Zhenyuan Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Zhenyuan Pharmaceutical Roxithromycin Product Portfolio
  6. 6.1.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Roxithromycin Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer AG Roxithromycin Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 Valeant Pharmaceutical International
  20. 6.4.1 Valeant Pharmaceutical International Company Information
  21. 6.4.2 Valeant Pharmaceutical International Business Overview
  22. 6.4.3 Valeant Pharmaceutical International Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Valeant Pharmaceutical International Roxithromycin Product Portfolio
  24. 6.4.5 Valeant Pharmaceutical International Recent Developments
  25. 6.5 Stiefel Laboratories
  26. 6.5.1 Stiefel Laboratories Company Information
  27. 6.5.2 Stiefel Laboratories Business Overview
  28. 6.5.3 Stiefel Laboratories Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stiefel Laboratories Roxithromycin Product Portfolio
  30. 6.5.5 Stiefel Laboratories Recent Developments
  31. 6.6 Sigma-Aldrich
  32. 6.6.1 Sigma-Aldrich Company Information
  33. 6.6.2 Sigma-Aldrich Business Overview
  34. 6.6.3 Sigma-Aldrich Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sigma-Aldrich Roxithromycin Product Portfolio
  36. 6.6.5 Sigma-Aldrich Recent Developments
  37. 6.7 Hygeia Laboratories
  38. 6.7.1 Hygeia Laboratories Company Information
  39. 6.7.2 Hygeia Laboratories Business Overview
  40. 6.7.3 Hygeia Laboratories Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hygeia Laboratories Roxithromycin Product Portfolio
  42. 6.7.5 Hygeia Laboratories Recent Developments
  43. 6.8 Hovione
  44. 6.8.1 Hovione Company Information
  45. 6.8.2 Hovione Business Overview
  46. 6.8.3 Hovione Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hovione Roxithromycin Product Portfolio
  48. 6.8.5 Hovione Recent Developments
  49. 6.9 Hetero Healthcare
  50. 6.9.1 Hetero Healthcare Company Information
  51. 6.9.2 Hetero Healthcare Business Overview
  52. 6.9.3 Hetero Healthcare Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hetero Healthcare Roxithromycin Product Portfolio
  54. 6.9.5 Hetero Healthcare Recent Developments
  55. 6.10 Galderma SA
  56. 6.10.1 Galderma SA Company Information
  57. 6.10.2 Galderma SA Business Overview
  58. 6.10.3 Galderma SA Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Galderma SA Roxithromycin Product Portfolio
  60. 6.10.5 Galderma SA Recent Developments
  61. 6.11 Finecure Pharmaceuticals
  62. 6.11.1 Finecure Pharmaceuticals Company Information
  63. 6.11.2 Finecure Pharmaceuticals Business Overview
  64. 6.11.3 Finecure Pharmaceuticals Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Finecure Pharmaceuticals Roxithromycin Product Portfolio
  66. 6.11.5 Finecure Pharmaceuticals Recent Developments
  67. 6.12 Cipher
  68. 6.12.1 Cipher Company Information
  69. 6.12.2 Cipher Business Overview
  70. 6.12.3 Cipher Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cipher Roxithromycin Product Portfolio
  72. 6.12.5 Cipher Recent Developments
  73. 6.13 Allergan
  74. 6.13.1 Allergan Company Information
  75. 6.13.2 Allergan Business Overview
  76. 6.13.3 Allergan Roxithromycin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Allergan Roxithromycin Product Portfolio
  78. 6.13.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Roxithromycin Sales by Country
  2. 7.1.1 North America Roxithromycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Roxithromycin Sales by Country (2021-2026)
  4. 7.1.3 North America Roxithromycin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Roxithromycin Market Size by Country
  6. 7.2.1 North America Roxithromycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Roxithromycin Market Size by Country (2021-2026)
  8. 7.2.3 North America Roxithromycin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Roxithromycin Sales by Country
  2. 8.1.1 Europe Roxithromycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Roxithromycin Sales by Country (2021-2026)
  4. 8.1.3 Europe Roxithromycin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Roxithromycin Market Size by Country
  6. 8.2.1 Europe Roxithromycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Roxithromycin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Roxithromycin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Roxithromycin Sales by Country
  2. 9.1.1 Asia-Pacific Roxithromycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Roxithromycin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Roxithromycin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Roxithromycin Market Size by Country
  6. 9.2.1 Asia-Pacific Roxithromycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Roxithromycin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Roxithromycin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Roxithromycin Sales by Country
  2. 10.1.1 South America Roxithromycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Roxithromycin Sales by Country (2021-2026)
  4. 10.1.3 South America Roxithromycin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Roxithromycin Market Size by Country
  6. 10.2.1 South America Roxithromycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Roxithromycin Market Size by Country (2021-2026)
  8. 10.2.3 South America Roxithromycin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Roxithromycin Sales by Country
  2. 11.1.1 Middle East and Africa Roxithromycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Roxithromycin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Roxithromycin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Roxithromycin Market Size by Country
  6. 11.2.1 Middle East and Africa Roxithromycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Roxithromycin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Roxithromycin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Roxithromycin Value Chain Analysis
  2. 12.1.1 Roxithromycin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Roxithromycin Production Mode & Process
  7. 12.2 Roxithromycin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Roxithromycin Distributors
  10. 12.2.3 Roxithromycin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst